Versartis Stock Price (NASDAQ:VSAR)

Add to My Stocks
$1.7 $0 (0%) VSAR stock closing price Feb 16, 2018 (Closing)
Prev Close* : $1.7
Market Cap:
$60.88M
Day Low: $1.65
52 Week Low: $1.60
Open: $1.7
Volume: -
Day High: $1.75
52 Week High: $24.00
Dividend:
0.00

Latest Stock Market News

Latest Articles

Versartis News - From Partners

VSAR Stockcharts

View VSAR PE ratio, PS ratio stocks charts and compare with peers.
VSAR Chart
Note: Compare Versartis stock price history with the index and industry peers.

Versartis Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Versartis Returns

ROE
(return on equity)

Versartis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

VSAR Industry Peers

Company Price Change (%)
Aevi Genomic (GNMX)2.240.01 (0.45%)
Agile Therapeutics (AGRX)3.690.04 (1.1%)
Opko Health (OPK)3.850.11 (2.78%)
Ascendis Pharma (ASND)55.810.02 (0.04%)
Novo Nordisk (NVO)51.860.3 (0.58%)
Capstone Therapeutics Corp. (CAPS)0.050 (0%)
Ascendis Pharma (ASND)55.810.02 (0.04%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)5.970.18 (3.11%)
Mylan (MYL)42.140.49 (1.18%)
Agile Therapeutics (AGRX)3.690.04 (1.1%)
Impax Lab (IPXL)19.60.2 (1.03%)
AEVI GENOMIC (GNMX)2.240.01 (0.45%)
Teva Pharmaceutical (TEVA)20.90.09 (0.43%)
Mallinckrodt (MNK)16.80.06 (0.36%)
Top gainers from Medical-Generic Drugs industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Aquinox Pharma (AQXP)14.621.69 (10.36%)
Supernus Pharma (SUPN)38.350.8 (2.04%)
Adamas Pharma (ADMS)33.770.66 (1.92%)
Corium (CORI)12.440.13 (1.03%)
Akorn (AKRX)31.850.1 (0.31%)
Allergan (AGN)164.040.43 (0.26%)
Top losers from Medical-Generic Drugs industry
* As of Feb 17, 2018

Versartis Inc Stock News - Partner Headlines

Versartis Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-95.81M-82.17M-57.51M-18.49M-13.21M
Total Operating Expense96.31M82.5M46.1M19.27M12.89M
View Versartis income statement
balance sheet20162015201420132012
Total Assets205.57M185.32M174.29M14.68M2.18M
Total Liabilities54.5M8.82M6.92M4.47M7.28M
Shareholders Equity151.06M176.5M167.36M10.2M-5.09M
View Versartis balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities44.04M2.22M1.24M1.97M1.03M
Net Cash from (used by) Operating Activities-40.63M-69.06M-39.65M-17.09M-11.71M
Increase (Decrease) in Prop Plant And Equipment-0.09M--0.82M-0.01M-
View Versartis cash flow statement

Versartis Stock Message Board

An investor needs to spend $1.7 to buy VSAR stock, as the closing Versartis stock price is $1.7. The total market value as denoted by $60.88M for Versartis, is the market value of the company's outstanding shares. Versartis valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Versartis is worth a lot, it will most likely be reflected in an inflated Versartis stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 707,975 on the last trading day, as is evident from Versartis stock chart, and VSAR stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Versartis stock dividend was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of VSAR, view Versartis stock price history.